Type 2 diabetes medications come in both oral and injectable forms. You should speak with your doctor about how you prefer to take your meds. It’s important that you feel you’ll be able to ...

Summary: Vildagliptin is an agent in a new class of medications called dipeptidyl ... and the increasing incidence of diabetes, more options for oral antidiabetic agents are warranted.

That procedure could be a real game changer for nearly half a billion people currently estimated to be living with the ...

Chinese insulin maker Gan & Lee Pharmaceuticals is wading into the obesity world with an injectable GLP-1 agonist that beat Novo Nordisk's Ozempic (semaglutide) at lowering glycated hemoglobin (HbA1c) ...

Dr. Crystal Aguh, a dermatologist and director of Johns Hopkins Medicine’s ethnic skin program, has had major breakthroughs in her research on the low-dose oral diabetes medication metformin’s ...

Groundbreaking research presented today at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) ...

People taking SGLT2 inhibitors were matched with people taking other oral diabetes drugs, so the two groups had people with similar ages, other health conditions and complications from diabetes.

Your insurance company very likely has a preferred oral treatment for Type 2 diabetes that should be both effective and affordable. Your doctor or pharmacist should be able to help you find out ...

Currently, the only FDA-approved OTC weight loss drug is Alli, which uses a 60-milligram dose of orlistat versus 120 ...

People prescribed SGLT2 inhibitors were compared with people taking other oral diabetes drugs. Alzheimer's disease among people on SGLT2 inhibitors was just under 40 cases per 10,000 person-years ...

The legislation, part of the now-defunct political agreement between the Liberals and the NDP, establishes a framework for ...

The surge in popularity of drugs like Ozempic, driven in part by its weight loss benefits, is contributing to a record-high ...